{"id":"https://openalex.org/W4283369170","doi":"https://doi.org/10.1017/cjn.2022.150","title":"P.049 Determining individual substantial response in amyotrophic lateral sclerosis: utilizing a new method on CENTAUR trial results","display_name":"P.049 Determining individual substantial response in amyotrophic lateral sclerosis: utilizing a new method on CENTAUR trial results","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4283369170","doi":"https://doi.org/10.1017/cjn.2022.150"},"language":"en","primary_location":{"id":"doi:10.1017/cjn.2022.150","doi":"https://doi.org/10.1017/cjn.2022.150","is_oa":true,"landing_page_url":"https://doi.org/10.1017/cjn.2022.150","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/F68093B444ACC79738872F0B0412C3AA/S0317167122001500a.pdf/div-class-title-p-049-determining-individual-substantial-response-in-amyotrophic-lateral-sclerosis-utilizing-a-new-method-on-centaur-trial-results-div.pdf","source":{"id":"https://openalex.org/S3196323","display_name":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","issn_l":"0317-1671","issn":["0317-1671","2057-0155"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/F68093B444ACC79738872F0B0412C3AA/S0317167122001500a.pdf/div-class-title-p-049-determining-individual-substantial-response-in-amyotrophic-lateral-sclerosis-utilizing-a-new-method-on-centaur-trial-results-div.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019201793","display_name":"T Jason","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T Jason","raw_affiliation_strings":["Cambridge)*"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cambridge)*","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013953419","display_name":"L Mehta","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L Mehta","raw_affiliation_strings":["Cambridge"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cambridge","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014443896","display_name":"Y Wu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y Wu","raw_affiliation_strings":["Cambridge"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cambridge","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004158980","display_name":"Jamie Timmons","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Timmons","raw_affiliation_strings":["Cambridge"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cambridge","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018168468","display_name":"Sabrina Paganoni","orcid":"https://orcid.org/0000-0003-0505-1168","observed_orcids":["https://orcid.org/0000-0003-0505-1168"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Paganoni","raw_affiliation_strings":["Boston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044584675","display_name":"Merit Cudkowicz","orcid":"https://orcid.org/0000-0002-7075-1681","observed_orcids":["https://orcid.org/0000-0002-7075-1681"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"ME Cudkowicz","raw_affiliation_strings":["Boston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2205,"currency":"USD","value_usd":2205},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"49","issue":"s1","first_page":"S20","last_page":"S21"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10855","display_name":"Amyotrophic Lateral Sclerosis Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10855","display_name":"Amyotrophic Lateral Sclerosis Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12400","display_name":"Neurogenetic and Muscular Disorders Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/amyotrophic-lateral-sclerosis","display_name":"amyotrophic lateral sclerosis","score":1.0},{"id":"https://openalex.org/keywords/individual-treatment-response","display_name":"individual treatment response","score":0.7549999952316284},{"id":"https://openalex.org/keywords/4-phenylbutyrate","display_name":"4-phenylbutyric acid","score":0.9789999723434448},{"id":"https://openalex.org/keywords/ursodeoxycholic-acid","display_name":"ursodeoxycholic acid","score":0.8040000200271606},{"id":"https://openalex.org/keywords/alsfrs-r","display_name":"ALSFRS-R","score":0.7329999804496765},{"id":"https://openalex.org/keywords/disease-progression-rate","display_name":"disease progression rate","score":0.8090000152587891},{"id":"https://openalex.org/keywords/personalized-medicine","display_name":"personalized medicine","score":0.7110000252723694}],"concepts":[{"id":"https://openalex.org/C2780596555","wikidata":"https://www.wikidata.org/wiki/Q206901","display_name":"Amyotrophic lateral sclerosis","level":3,"score":0.7979748249053955},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5758253931999207},{"id":"https://openalex.org/C2992459003","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo response","level":4,"score":0.5407874584197998},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.5041481256484985},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.43360480666160583},{"id":"https://openalex.org/C99508421","wikidata":"https://www.wikidata.org/wiki/Q2678675","display_name":"Physical medicine and rehabilitation","level":1,"score":0.4155256748199463},{"id":"https://openalex.org/C176217482","wikidata":"https://www.wikidata.org/wiki/Q860554","display_name":"Metric (unit)","level":2,"score":0.414486825466156},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3643750548362732},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.36314496397972107},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.35783547163009644},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.13998648524284363},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.09650281071662903},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C21547014","wikidata":"https://www.wikidata.org/wiki/Q1423657","display_name":"Operations management","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1017/cjn.2022.150","doi":"https://doi.org/10.1017/cjn.2022.150","is_oa":true,"landing_page_url":"https://doi.org/10.1017/cjn.2022.150","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/F68093B444ACC79738872F0B0412C3AA/S0317167122001500a.pdf/div-class-title-p-049-determining-individual-substantial-response-in-amyotrophic-lateral-sclerosis-utilizing-a-new-method-on-centaur-trial-results-div.pdf","source":{"id":"https://openalex.org/S3196323","display_name":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","issn_l":"0317-1671","issn":["0317-1671","2057-0155"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1017/cjn.2022.150","doi":"https://doi.org/10.1017/cjn.2022.150","is_oa":true,"landing_page_url":"https://doi.org/10.1017/cjn.2022.150","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/F68093B444ACC79738872F0B0412C3AA/S0317167122001500a.pdf/div-class-title-p-049-determining-individual-substantial-response-in-amyotrophic-lateral-sclerosis-utilizing-a-new-method-on-centaur-trial-results-div.pdf","source":{"id":"https://openalex.org/S3196323","display_name":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","issn_l":"0317-1671","issn":["0317-1671","2057-0155"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4283369170.pdf","grobid_xml":"https://content.openalex.org/works/W4283369170.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4205984616","https://openalex.org/W3092893535","https://openalex.org/W4387439424","https://openalex.org/W4389264458","https://openalex.org/W4229000223","https://openalex.org/W4224992211","https://openalex.org/W3082968199","https://openalex.org/W4280584569","https://openalex.org/W3159789596","https://openalex.org/W4380149587"],"abstract_inverted_index":{"Background:":[0],"In":[1,60],"ALS,":[2],"determining":[3],"whether":[4],"individuals":[5,33],"have":[6,34,165],"a":[7,13,25,35,61,93,108,127,166,175,181],"substantial":[8,36,94,132,167,182],"response":[9,44,96,104,134,184,199],"to":[10,30,41,49,130,141,147,164,171],"therapy":[11],"is":[12,28,45],"challenge":[14],"for":[15],"the":[16,52,75,159,186],"field.":[17],"ALS":[18,99],"naturally":[19],"progresses":[20],"at":[21,77],"variable":[22],"rates":[23],"and":[24,47,195],"personalized":[26,128],"approach":[27],"required":[29],"determine":[31,131],"if":[32],"response.":[37,169],"A":[38],"new":[39],"method":[40],"evaluate":[42],"individual":[43,95,103,133,168,183,198],"proposed":[46],"applied":[48],"data":[50,173],"from":[51,72],"CENTAUR":[53,65,172],"trial":[54,84],"of":[55,70,111,178,197],"sodium":[56],"phenylbutyrate/ursodoxicoltaurine":[57],"(PB/TURSO).":[58],"Methods:":[59],"post":[62],"hoc":[63],"analysis,":[64],"participants":[66,112,179],"whose":[67],"actual":[68],"rate":[69,87],"change":[71],"baseline":[73,85],"in":[74,97,107,135,152,185,200],"ALSFRS-R":[76,150],"week":[78],"18":[79],"was":[80,105],"\u2264":[81],"their":[82],"own":[83],"progression":[86],"(\u0394FS)":[88],"were":[89],"defined":[90],"as":[91],"having":[92],"slowing":[98],"progression.":[100],"Results:":[101],"Substantial":[102],"observed":[106],"greater":[109,176,193],"proportion":[110,177],"receiving":[113],"PB/TURSO":[114,187],"(41%,":[115],"n=87)":[116],"vs":[117],"placebo":[118],"(19%,":[119],"n=48;":[120],"P=0.0076).":[121],"Conclusions:":[122],"Response":[123],"versus":[124],"\u0394FS":[125,137,160],"provides":[126],"metric":[129],"ALS.":[136,201],"has":[138],"been":[139],"shown":[140],"be":[142,162],"highly":[143],"correlated":[144],"with,":[145],"but":[146],"proportionally":[148],"underestimate,":[149],"decline":[151],"clinical":[153],"trials.":[154],"Consequently,":[155],"those":[156],"who":[157],"outperform":[158],"may":[161,191],"considered":[163],"Application":[170],"demonstrates":[174],"with":[180],"arm.":[188],"These":[189],"methods":[190],"enable":[192],"personalization":[194],"analysis":[196]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-06-25T00:00:00"}